Carlos Gomez-Lopez Downgraded (BMA) to Sell on, Jul 21st, 2020
Carlos, nor any peers, have made any analyst calls on BMA in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30on: Mon, Sep 11th 2017
by: WOPRAI
on: Fri, Jul 21st 2017
by: WOPRAI
on: Thu, Jul 02nd 2020
by: WOPRAI
Carlos Laboy Maintained (STZ) at Hold with Increased Target to $170 on, Jul 2nd, 2020
on: Fri, Dec 20th 2019
by: WOPRAI
on: Tue, Aug 13th 2019
by: WOPRAI
Carlos Gomez-Lopez Upgraded (BAP) to Strong Buy and Increased Target to $250 on, Aug 13th, 2019
on: Mon, Jul 22nd 2019
by: WOPRAI
Domingos Falavina Maintained (BMA) at Hold with Increased Target to $61 on, Jul 22nd, 2019
on: Fri, Jul 21st 2017
by: WOPRAI
on: Thu, Feb 16th 2017
by: WOPRAI
Domingos Falavina Downgraded (BMA) to Hold on, Feb 16th, 2017
on: Mon, Sep 26th 2016
by: WOPRAI
Carlos Macedo Upgraded (BMA) to Strong Buy and Increased Target to $87 on, Sep 26th, 2016
on: Mon, Jul 20th 2020
by: WOPRAI
Simeon Gutman Maintained (WMT) at Buy with Increased Target to $50 on, Jul 20th, 2020
on: Mon, Jul 20th 2020
by: WOPRAI
Laura Champine Downgraded (URBN) to Strong Sell and Decreased Target to $14 on, Jul 20th, 2020
on: Mon, Jul 20th 2020
by: WOPRAI
Timothy Wojs Maintained (ALLE) at Hold with Increased Target to $102 on, Jul 20th, 2020